Vitamin B3 prices firming, in an otherwise calm vitamin market

Tight availability, and higher prices of key raw material have initiated this increase. The rest of the vitamin market shows no significant changes and is very quiet.

In partnership with Feed Additive Prices

Vitamin E 50%

No changes reported in the vitamin E market, compared to previous weeks. The market is still very quiet and well contracted into Q2. The manufacturers are not lowering their price offers any further currently and that has led to mostly stable prices in all regions. Some traders seem to still have some excess stock and are offering this slightly below the prices of the manufacturers.

Vitamin A 1000

No changes reported in the vitamin A1000 market, compared to previous weeks. In most regions, the price has been stable for some time now. Some minor decline is seen sometimes in the EU and USA, mostly coming from traders trying to move volume. But manufacturers have been stable on prices. Q2 is mostly contracted and in some cases a portion of Q3 as well, as buyers find the risk acceptable at the current price levels. The market feels very quiet though.

Vitamin D3 500

Very quiet market in general and well contracted ahead. Spot prices have firmed in most regions, but there is not a lot of new volumes contracted at the moment. Still some uncertainties around the import procedure into the EU market for Chinese origin, which leads to potential question marks around availability in the upcoming summer.

D-Calpan

The d-calpan market is very steady and calm at the moment. There is a decent cover on Q2, but that also goes with a lot of hand-to-mouth buying. Several buyers believe that the price may decline further. Prices ex China have been stable for some time as manufacturers are reluctant to go down further right now.

Vitamin B3

A rather significant price increase is seen for Chinese origin on a FOB China basis. Availability and raw material prices are the main drivers, it is said. In the other regions, prices have also been firmer. There is already a large contract cover well into 2023, and the additional/spot demand is therefore limited. Although the question is if contract execution and availability will be in order. The market is a bit more active now.